Literature DB >> 11150867

Distribution of study designs in four major US journals of obstetrics and gynecology.

E F Funai1, E J Rosenbush, M J Lee.   

Abstract

OBJECTIVE: To classify and compare articles, based on the study design, in four leading US obstetrics and gynecology journals.
METHODS: One year of each journal, American Journal of Obstetrics and Gynecology (AJOG), Obstetrics and Gynecology (O&G), Gynecologic Oncology (GO), and Fertility and Sterility (F&S), beginning May 1997, was reviewed. Supplementary issues were excluded from review. The percentage of articles devoted to observational versus experimental study design was determined, and the quality of evidence was assessed including how heavily randomized controlled trials were represented versus other study designs.
RESULTS: 1,517 articles were reviewed. The average percentage of clinical research articles was 90.4. The percentage of animal studies were 10.7 (AJOG), 1.1 (O&amp;G), 1.1 (GO) and 4.2 (F&amp;S) (chi(2) p < 0.001). There were 5.3, 1.9, 6.5, and 7.5% basic science articles, respectively (chi(2) p = 0.007). The average percentage of observational articles was 68.2 and that of experimental articles was 14.1. The percentages of total articles classified as controlled experimental were 10.9 (AJOG), 14.6 (O&amp;G), 5.1 (GO), and 15.2 (F&amp;S) (chi(2) p = 0.01). There were 8.7, 11.1, 3.3 and 9.5% randomized controlled trials, respectively (chi(2) p = 0.008).
CONCLUSIONS: The majority of research reviewed was clinical, and more than half of the articles were observational. Under the US Preventative Services Task Force rating system, the randomized control trial is given the highest rating - class I evidence. The drive toward evidence-based clinical practice may not be fully supported by researchers in obstetrics and gynecology, as reflected by submissions to and publications in the major obstetrics and gynecology journals. Copyright 2001 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2001        PMID: 11150867     DOI: 10.1159/000052882

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  7 in total

1.  [Minimum requirements for high quality reporting of medical research results : CONSORT, STROBE and PRISMA statements].

Authors:  A Stevanovic; M Coburn; R Rossaint
Journal:  Anaesthesist       Date:  2015-12       Impact factor: 1.041

2.  Methodology and analytic techniques used in clinical research: associations with journal impact factor.

Authors:  Lindsay M Kuroki; Jenifer E Allsworth; Jeffrey F Peipert
Journal:  Obstet Gynecol       Date:  2009-10       Impact factor: 7.661

Review 3.  Antimicrobial agent exposure and the emergence and spread of resistant microorganisms: issues associated with study design.

Authors:  C Angebault; A Andremont
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-12-27       Impact factor: 3.267

4.  Methods to systematically review and meta-analyse observational studies: a systematic scoping review of recommendations.

Authors:  Monika Mueller; Maddalena D'Addario; Matthias Egger; Myriam Cevallos; Olaf Dekkers; Catrina Mugglin; Pippa Scott
Journal:  BMC Med Res Methodol       Date:  2018-05-21       Impact factor: 4.615

Review 5.  Scoping review and bibliometric analysis of Big Data applications for Medication adherence: an explorative methodological study to enhance consistency in literature.

Authors:  Salvatore Pirri; Valentina Lorenzoni; Giuseppe Turchetti
Journal:  BMC Health Serv Res       Date:  2020-07-24       Impact factor: 2.655

Review 6.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

Authors:  Jan P Vandenbroucke; Erik von Elm; Douglas G Altman; Peter C Gøtzsche; Cynthia D Mulrow; Stuart J Pocock; Charles Poole; James J Schlesselman; Matthias Egger
Journal:  PLoS Med       Date:  2007-10-16       Impact factor: 11.069

Review 7.  How to avoid describing your radiological research study incorrectly.

Authors:  Steve Halligan; Shedrack F Kenis; Oshaani Abeyakoon; Andrew A O Plumb; Susan Mallett
Journal:  Eur Radiol       Date:  2020-02-21       Impact factor: 5.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.